BioSpace News Archive

Tetra Bio-Pharma Inc. (TSX: TBP) (OTCQB: TBPMF) , a biopharmaceutical pioneer in immunomodulator drug discovery and development wishes to make the following correction to its news release dated February 25th, 2021. In the statement attributed to DanCann Pharma CCO John Morell Frellsen, the estimate of peak sales by 2026 is cited at $55M DKK.

● Compositions and Methods for Enhancing Anti-viral Therapies ● CALGARY, Alberta, March 08, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE: XRX; OTCQB: XRTXF), a biopharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, with late-stage clinical programs, is pleased to announce the filing of a new provisional patent application entitled “Compositions and Methods for Enhancing Anti-Viral Therapies”.

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it intends to offer $1 billion aggregate principal amount of senior notes due 2029 and 2031 (the “notes”) in an unregistered offering, subject to market conditions.

Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, announces the U.S. Food and Drug Administration (FDA) clearance of the new Cochlear™ Baha® 6 Max Sound Processor, designed to improve hearing outcomes for people with SSD (single-sided deafness),

The advanced medical equipment industry chain includes various fields, such as materials, design, components, parts manufacturing, and complete machine manufacturing.

Roman Fischer of Oxford University demonstrates high-throughput 4D proteomics on non-depleted, untreated plasma identifying >350 protein groups with short 10-20 minute methods, enabling high throughput, robust biomarker discovery OmicEra Diagnostics reports running 720 undepleted serum samples from 31 COVID-19 patients over just 12 days on a single timsTOF Pro system at a rate of 60 samples/day

CorNeat Vision, a clinical-stage, biomimetic implant and technology company, and LiveU, a company offering high quality live video streaming and remote production solutions, announced that they have partnered and successfully implemented an on-demand Remote Surgeon Virtual Presence solution.

Hyperfine Research has been named by Fierce Medtech as one of 2020’s Fierce 15, designating it as one of the most innovative and creative private companies in the industry with its category-defining Swoop™ Portable MR Imaging System.

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market and the JASDAQ Market of the Tokyo Stock Exchange, announced that MediciNova will present at the Inaugural Emerging Growth Virtual Conference, presented by M Vest LLC and Maxim Group LLC.

NovaBay Pharmaceuticals to Participate in Virtual 33 rd Annual Roth Conference